首页|期刊导航|昆明医科大学学报|典型心绞痛合并中重度钙化病变的冠心病患者应用可视Stent Boost支架精显指导介入治疗的效果

典型心绞痛合并中重度钙化病变的冠心病患者应用可视Stent Boost支架精显指导介入治疗的效果OA

Efficacy of Visual Stent Boost-guided Percutaneous Coronary Intervention in Patients with Typical Angina Pectoris and Moderate-to-severe Calcified Lesions

中文摘要英文摘要

目的 探讨可视支架影像增强显影技术(Stent Boost)精显指导典型心绞痛合并中重度钙化病变的冠心病患者介入治疗的效果.方法 前瞻性选取2022年1月至2024年1月180例重庆渝北区中医院典型心绞痛合并中重度钙化病变的冠心病患者作为研究对象,按照随机数字表法分为对照组(n=90)与实验组(n=90),并根据实际病情分为中度钙化亚组(n=30)、重度钙化亚组(n=30)、特殊人群亚组(n=30).对照组采用标准支架植入治疗方案,实验组采用可视Stent Boost精显指导+标准支架植入治疗方案,支架均选择药物洗脱支架.比较两组术中操作便利性及手术效果,以及手术前后心功能指标[左心室射血分数(left ventricular ejection fraction,LVEF)、左心室收缩末期容积(left ventricular end-systolic volume,LVESV)、左心室舒张末期容积(left ventricular end-diastolic volume,LVEDV)]、并发症.并随访12个月,观察对比两组靶病变血运重建、主要不良心血管事件(major adverse cardiovascular events,MACE)事件.结果 实验组术中即刻支架可视性优良率、支架膨胀率、最小支架管腔直径、最大支架边缘直径、最小支架管腔面积(minimal stent area,MSA)、偏心指数、LVEF均高于对照组,且后扩张率、手术时间、对比剂用量、LVESV、LVEDV均低于对照组(P<0.05);实验组术后即刻心肌梗死溶栓治疗(thrombolysis in myocardial infarction,TIMI)分级3级血流比例高于对照组,并发症发生率、MACE发生率低于对照组(P<0.05);但两组中度钙化亚组、重度钙化亚组、特殊人群亚组术后即刻TIMI3级血流比例单独比较,差异均无统计学意义(P>0.05);两组中度钙化亚组、重度钙化亚组患者并发症发生率、MACE发生率比较,差异无统计学意义(P>0.05);实验组中特殊人群亚组并发症发生率、MACE发生率低于对照组的特殊人群亚组(P<0.05).结论 对于典型心绞痛合并中重度钙化病变的冠心病患者,Stent Boost指导PCI可优化治疗效果,改善术后心功能,降低并发症及MACE发生率,尤其在重度钙化合并分叉病变的患者中价值显著.

Objective To explore the efficacy of Stent Boost-guided percutaneous coronary intervention(PCI)in treating coronary artery disease(CAD)patients with typical angina pectoris and moderate to severe calcified lesions.Methods A prospective study enrolled 180 CAD patients with typical angina pectoris and moderate-to-severe calcified lesions from January 2022 to January 2024.Patients were randomly divided into control group(n=90)and experimental group(n=90),further stratified into three subgroups:moderate calcification subgroup(n=30),severe calcification subgroup(n=30),and special population subgroup(n=30).The control group received standard stent implantation,while the experimental group received Stent Boost-guided visualization combined with standard stent implantation.All patients received drug-eluting stents.We compared intraoperative convenience and efficacy,cardiac function parameters[left ventricular ejection fraction(LVEF),left ventricular end-systolic volume(LVESV),left ventricular end-diastolic volume(LVEDV)],and complications between the two groups.The patients were followed up for 12 months,and the target lesion revascularization and major adverse cardiovascular events(MACE)events were assessed between the two groups.Results The experimental group demonstrated superior immediate stent visibility,stent expansion rate,minimum stent lumen diameter,maximum stent edge diameter,minimal stent area(MSA),eccentricity index,and LVEF compared to controls.Post-dilation rate,operative time,contrast volume,LVESV,and LVEDV were significantly lower in the experimental group(P<0.05).The experimental group showed higher proportion of Thrombolysis In Myocardial Infarction(TIMI)grade 3 flow immediately post-procedure,with lower complication and MACE rates(P<0.05),However,TIMI grade 3 flow proportions showed no significant difference among subgroups between groups(P>0.05).Complication and MACE rates were similar between groups in moderate and severe calcification subgroups(P>0.05),while the special population subgroup showed significantly lower complication and MACE rates in the experimental group(P<0.05).Conclusion For CAD patients with typical angina and moderate-to-severe calcified lesions,Stent Boost-guided PCI optimizes treatment outcomes,improves post-operative cardiac function,and reduces complications and MACE rates,particularly in patients with severe calcification and bifurcation lesions.

陈红梅;赵郑波;胡云;李俊

重庆市渝北区中医院心病科,重庆 401120重庆市渝北区中医院心病科,重庆 401120重庆市渝北区中医院心病科,重庆 401120重庆市渝北区中医院心病科,重庆 401120

医药卫生

冠心病冠状动脉钙化经皮冠状动脉介入治疗支架影像增强显影技术

Coronary heart diseaseCoronary artery calcificationPercutaneous coronary intervention therapyStent Boost

《昆明医科大学学报》 2026 (8)

146-157,12

重庆市渝北区科卫联合医学科研项目(2023YBKW18)

10.12259/j.issn.2095-610X.S20260815

评论